banner

Latest News

Civilization Ventures: Holiday Event to Celebrate Women in Science

Celebrating Women Leaders in HealthcareCivilization Ventures and First Republic Bank’s Tech and Venture Team hosted a holiday event celebrating female founders' unique opportunities and challenges.An investor and founder panel was followed by cocktails and appetizers. The audience is a co-ed group of founders and investors.Linda AveyPrecise.ly, Co-founder and CEO; 23andMe, Co-founder Abril Estr...

Read More

What do Bollywood and Rocket Pharma have in common? Possibly a Grammy.

Gaurav Shah, CEO of Rocket Pharmaceuticals, is a man of many talents. In his spare time, he joins his wife, Falguni Shah, on stage to perform her music in Hindi, English, and Gujarati under the stage name of Falu. Gaurav is featured on her most recent album, Falu's Bazaar, which was recently nominated for a Grammy. Falu composes her own music and lyrics in a style she calls Indie Hindi, a ...

Read More

Prellis Biologics, Inc. Announces Vascular Tissue Blanks™, a Series of Ready to Use, Pre-Vascularized Tissue Scaffolds for Complex 3D Cell and Tissue Cultures and Transplantation

From Business Wire:Tissue engineering company Prellis Biologics launched the first ever line of pre-vascularized 3D (three-dimensional) tissue scaffolds today. The scaffolds are biocompatible and can be used by researchers to grow any cell type in 3D formats 1000x larger than 3D spheroids. For the first time, therapeutics can be tested on accurate, easily replicated, fast to set-up mo...

Read More

BioPrinting with Alzheimer’s Stem Cells May Lead to Improved Drug Testing & Treatment

From 3DPrint.com: BioPrinting with Alzheimer’s Stem Cells May Lead to Improved Drug Testing & Treatment Alzheimer’s studies give many of us hope, whether we have a relative or friend suffering from the dreaded disease—or simply because we are hoping that a cure will be there if we begin to experience symptoms of the most common and crushing form of dementia. As bioprinting becomes valua...

Read More

Synthetic biology: A call for a new culture of responsibility

From Bulletin of the Atomic ScientistsBy Ali Nouri, Shahram Seyedin-Noor (General Partner, Civilization Ventures), December 7, 2018 In 1980, the World Health Organization declared the official eradication of smallpox.This was one of modern medicine’s crowning achievements—the elimination of a virus estimated to have killed more than 300 million people in the 20th century. That’s...

Read More

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia

From Business Wire:NEW YORK--Nov. 27, 2018-- Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announces that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations to RP-L102, the Company’s lentiviral vector (LVV)-based gene therap...

Read More

Evonetix "Highly Commended" at Cambridge Independent Science and Technology Awards 2018

From Cambridge Independent Science and Technology Awards 2018: Evonetix Highly CommendedThe winners of the 2018 Cambridge Independent Science and Technology Awards were unveiled at a ceremony at the Hilton City Centre Hotel hosted by editor Paul Brackley, who chaired the judging panel for the awards.HIGHLY COMMENDED, Startup of the Year Award: EvonetixEvonetix, based on Chesterford Research Par...

Read More

Silicone Valley Bank: Trends in Healthcare Investments and Exits 2018

A recent  report by SVB highlights Civilization Ventures: Fundraising is on pace to match the 2017 total of $9.1B – counter to our early 2018 prediction that the annual total would decline. A confluence of events is driving investment and fundraising to new levels. Rapid technological advances, leading to clinical breakthroughs, are benefiting patients and investors alike. In t...

Read More


Blood Test to Detect Prenatal Genetic Defects to Soon be a Reality

A recent article on BillionToOne: A unique healthcare innovation by a young Indian scientist has the potential to radically change how prenatal genetic testing is done to identify fetal abnormalities. FIT interviews Sukrit Silas, a PhD from Stanford and the Chief Science Officer at BillionToOne, a Y Combinator Company. They’ve developed a non-invasive pre...

Read More